Category: Research

Month: 16 May 2012

Issue: not yet available

Mitochondrial gene therapy shows potential application in Leber’s hereditary optic neuropathy (LHON)

Research published in the US journal Proceedings of the National Academy of Sciences (PNAS) has shown that gene delivery to mitochondria is capable of suppressing visual loss and optic atrophy in an experimental model of Leber’s hereditary optic neuropathy (LHON). The results may be expected to have important implications not only for LHON but also for a broad range of human disorders brought about through mitochondrial gene defects.

Back to previous

Related News

Gearoid Tuohy


by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the December 3rd, 2018 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]